Abstract:A population of reserve HSCs has been reported to be in a deep-quiescent (or dormant) state and function as a back-up population of HSCs to support life-time hematopoiesis (Li and Clevers, 2010; Wilson et al., 2008). Currently, characterization of reserve HSCs is mainly based on cell cycle quiescence, however, the metabolic state in reserve HSCs is yet to be defined. Here, we show that reserve HSCs maintain not only a quiescent state but also an overall low metabolic activity whereas the primed HSCs maintain still a quiescent state but primed at metabolic state. First, we used CD49b(Benveniste et al., 2010) to further separate conventional long-term (LT) HSCs (CD34 - Flk2 - Lineage - Sca-1 + c-Kit + )(Yang et al., 2005) into CD49b lo and CD49b hi subpopulations and confirmed their enrichment with previously identified dormant (Scl-H2B-GFP label retaining cells, LRCs), thus we termed CD49b lo and CD49b hi subpopulations as candidates of reserve and primed HSCs. We then determined the cell cycle frequencies of reserve, primed, and ST-HSCs (Cd34 + Flk2 - LSK) respectively as once in 3 months, 3-4 weeks, and 3-4 days. Functionally, Reserve HSCs had on average 3.5-fold higher functional capacity compared with primed HSCs. RNA-seq analysis revealed that reserve HSC predominantly expressed a list of imprinting genes that associate with growth-restriction functions; primed HSCs expressed relatively-high number of genes involving in mitochondria fusion, organization, and function, while ST-HSCs expressed genes reflecting an active cycling state. Conducting metabolic assays, we found that reserve HSCs not only maintain quiescence but also maintain overall low metabolic activity in both glycolysis and mitochondrial capacity. In contrast, primed HSCs are in a quiescent state, but with their metabolic state primed as evidenced by an increased glycolytic activity and mitochondrial potential for subsequent active proliferating state in ST-HSCs. Intriguingly, our data suggests that the functionality of reserve HSCs correlates to metabolic state rather than cell cycle. Disclosures No relevant conflicts of interest to declare.

Dissecting dormancy and quiescence in hematopoietic stem cells

Molecular Regulation of Hematopoietic Stem Cell Quiescence

Metabolic Activity Distinguish Reserve and Primed HSCs

Discrimination of Dormant and Active Hematopoietic Stem Cells by G0 Marker Reveals Dormancy Regulation by Cytoplasmic Calcium

CD38 promotes hematopoietic stem cell dormancy

Hyaluronic acid–GPRC5C signalling promotes dormancy in haematopoietic stem cells

Stem cell quiescence and its clinical relevance

The essence of quiescence

Expansion of Quiescent Hematopoietic Stem Cells under Stress and Nonstress Conditions in Mice

3128 – HYALURONIC ACID- GPRC5C SIGNALLING PROMOTES DORMANCY IN HEMATOPOIETIC STEM CELLS

Genetic and Epigenetic Mechanisms That Maintain Hematopoietic Stem Cell Function

Regulation of adult stem cell quiescence and its functions in the maintenance of tissue integrity

Hematopoietic Stem Cell Quiescence Maintained by P21 Cip1/waf1

Both intrinsic and microenvironmental factors contribute to the regulation of stem cell quiescence

Hematopoietic stem cell quiescence and DNA replication dynamics maintained by the resilient β-catenin/Hoxa9/Prmt1 axis

From ecology to oncology: To understand cancer stem cell dormancy, ask a Brine shrimp (<i>Artemia</i>)

Cyclin C Regulates Human Hematopoietic Stem/Progenitor Cell Quiescence

Regulation of Hematopoietic Stem Cells Differentiation, Self-Renewal, and Quiescence Through the Mtor Signaling Pathway

Chromatin Remodeler Znhit1 Preserves Hematopoietic Stem Cell Quiescence by Determining the Accessibility of Distal Enhancers

Bone marrow Schwann cells induce hematopoietic stem cell hibernation

DNA Damage Response in Quiescent Hematopoietic Stem Cells and Leukemia Stem Cells.